|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of May 10, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash | |||||||||||
| Prepaid expenses | |||||||||||
| Total current assets | |||||||||||
| Cash held in trust account | |||||||||||
| Deferred tax asset | |||||||||||
| Total assets | |||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable and accrued liabilities | |||||||||||
| Notes payable, affiliates | |||||||||||
| Income tax payable | |||||||||||
| Total current liabilities | |||||||||||
| Deferred underwriting commissions | |||||||||||
| Warrant liability | |||||||||||
| Total liabilities | |||||||||||
| Class A common stock subject to possible redemption, 1,058,523 shares at $10.44 per share and 1,357,537 shares at $10.20 per share at September 30, 2023 and December 31, 2022, respectively | |||||||||||
| Stockholders' Deficit: | |||||||||||
| Preferred stock, $0.0001 par value, 1,000,000 authorized, no shares issued or outstanding | |||||||||||
| Common stock | |||||||||||
| Class A common stock | |||||||||||
| Common Class B | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Subscription notes receivable, affiliates | |||||||||||
| Total stockholders' deficit | |||||||||||
| Total liabilities and stockholders' deficit |
Loading...
